Miniatura

Fitxers

667844.pdf (6.42 MB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2017-07-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/167320

Novel indole-based tambjamine-analogues induce apoptotic lung cancer cell death through p38 mitogen-activated protein kinase activation

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1158/1535-7163.MCT-16-0752

Resum

Lung cancer has become the leading killer cancer worldwide, due to late diagnosis and lack of efficient anticancer drugs. We have recently described novel natural-derived tambjamine analogues that are potent anion transporters capable of disrupting cellular ion balance, inducing acidification of the cytosol and hyperpolarization of cellular plasma membranes. Although these tambjamine analogues were able to compromise cell survival, their molecular mechanism of action remains largely unknown. Herein we characterize the molecular cell responses induced by highly active indole-based tambjamine analogues treatment in lung cancer cells. Expression changes produced after compounds treatment comprised genes related to apoptosis, cell cycle, growth factors and its receptors, protein kinases and topoisomerases, among others. Dysregulation of BCL2 and BIRC5/survivin genes suggested the apoptotic pathway as the induced molecular cell death mechanism. In fact, activation of several proapoptotic markers (caspase-9, caspase-3, and PARP) and reversion of the cytotoxic effect upon treatment with an apoptosis inhibitor (Z-VAD-FMK) were observed. Moreover, members of the Bcl-2 protein family suffered changes after tambjamine analogues treatment, with a concomitant protein decrease towards the prosurvival members. Besides this, it was observed cellular accumulation of ROS upon compound treatment and an activation of the stress-kinase p38 MAPK route that, when inhibited, reverted the cytotoxic effect of the tambjamine analogues. Finally, a significant therapeutic effect of these compounds was observed in subcutaneous and orthotopic lung cancer mice models. Taken together, these results shed light on the mechanism of action of novel cytotoxic anionophores and demonstrate the therapeutic effects against lung cancer. Mol Cancer Ther; 16(7); 1224-35. ©2017 AACR.

Matèries

Apoptosi, Efectes secundaris dels medicaments, Càncer de pulmó, Pirroles, Genètica

Matèries (anglès)

Apoptosis, Drug side effects, Lung cancer, Pyrroles, Genetics

Citació

Col·leccions

Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

MANUEL-MANRESA, Pilar, KORRODI-GREGÓRIO, Luís, HERNANDO, Elsa, VILLANUEVA GARATACHEA, Alberto, MARTÍNEZ GARCÍA, David, RODILLA MARTÍN, Ananda marina, RAMOS IZQUIERDO, Ricard, FARDILHA, Margarida, MOYA AMORÓS, Juan, QUESADA, Roberto, SOTO CERRATO, Vanessa, PÉREZ TOMÁS, Ricardo e.. Novel indole-based tambjamine-analogues induce apoptotic lung cancer cell death through p38 mitogen-activated protein kinase activation. _Molecular Cancer Therapeutics_. 2017. Vol. 16, núm. 7, pàgs. 1224-1235. [consulta: 11 de gener de 2026]. ISSN: 1535-7163. [Disponible a: https://hdl.handle.net/2445/167320]

Exportar metadades

JSON - METS

Compartir registre